Computerized cardiotocography in pregnancies complicated by maternal asthma
Carregando...
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
INFORMA HEALTHCARE
Citação
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, v.25, n.7, p.1077-1079, 2012
Resumo
Objective: The aim of the present study was to investigate the FHR parameters in term pregnancies complicated by asthma. Study design: prospective cross-sectional study performed between July 2008 and November 2009. Twenty-one singleton pregnancy between 36 and 40 weeks gestation with diagnosis of maternal asthma and no current use of oral corticosteroids were compared with 30 pregnancies without morbidities at the same gestational age. The computerized cardiotocography (System 8002, Sonicaid) was performed and 30 min analysis was studied. Statistical analysis included Student's t-test or Mann-Whitney U test for comparisons between groups. Categorical data were compared using the chi(2)-test or Fisher's exact test. Results: There were no significant differences in FHR parameters analyzed by computerized cardiotocography: basal FHR (p = 0.80), number of accelerations >10 bpm (p = 0.08) or >15 bpm (p = 0.20), duration of high episodes (p = 0.70), duration of low episodes (p = 0.46) and STV (p = 0.66). Asthmatic mothers presented mean number of fetal movement per hour significantly lower than control group (34.6 +/- 28.2 vs. 60.6 +/- 43.1, p = 0.02). Conclusion: Computerized cardiotocography demonstrates no association between the abnormal parameters of FHR and maternal asthma in term pregnancies. Maternal asthma was associated with less fetal movements per hour, suggesting further studies on the counting of fetal movements in pregnant women with asthma.
Palavras-chave
Asthma, pregnancy, fetal heart rate, cardiotocography
Referências
- Bakhireva LN, 2008, ANN ALLERG ASTHMA IM, V101, P137, DOI 10.1016/S1081-1206(10)60201-3
- Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5
- Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970
- Cousins L, 1999, J ALLERGY CLIN IMMUN, V103, pS343, DOI 10.1016/S0091-6749(99)70260-5
- Dawes GS, 2005, J PERINAT MED, V33, P241
- Dombrowski MP, 2010, CLIN OBSTET GYNECOL, V53, P301, DOI 10.1097/GRF.0b013e3181de8906
- Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P363, DOI 10.1007/s00228-006-0257-1
- Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5
- LEINER GC, 1963, AM REV RESPIR DIS, V88, P644
- Murphy VE, 2005, EUR RESPIR J, V25, P731, DOI 10.1183/09031936.05.00085704
- Murphy VE, 2005, OBSTET GYNECOL, V106, P1046, DOI 10.1097/01.AOG.0000185281.21716.02
- Murphy VE, 2007, PLACENTA, V28, P39, DOI 10.1016/j.placenta.2005.12.010
- Nomura Roseli Mieko Yamamoto, 2010, Rev Bras Ginecol Obstet, V32, P420, DOI 10.1590/S0100-72032010000900002
- Pardey J, 2002, AM J OBSTET GYNECOL, V186, P1095, DOI 10.1067/mob.2002.122447
- Schatz M, 2004, J ALLERGY CLIN IMMUN, V113, P1040, DOI 10.1016/j.jaci.2004.03.017
- Schatz M, 2009, NEW ENGL J MED, V360, P1862, DOI 10.1056/NEJMcp0809942
- Serra V, 2009, ULTRASOUND OBST GYN, V34, P74, DOI 10.1002/uog.6365
- Tveit JVH, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-32
- Yawn B, 2007, J AM BOARD FAM MED, V20, P289, DOI 10.3122/jabfm.2007.03.060144